68Ga-PSMA-PET screening and transponder-guided salvage radiotherapy to the prostate bed alone for biochemical recurrence following prostatectomy: interim outcomes of a phase II trial

ConclusionPre-SRT68Ga-PSMA-PET scans detect metastatic disease in a proportion of patients at low PSA levels but fail to improve FFBR. Transponder-guided SRT to the prostate bed alone is associated with a favourable toxicity profile and preserved QoL.Trial registration numberACTRN12615001183572, 03/11/2015, retrospectively registered.
Source: World Journal of Urology - Category: Urology & Nephrology Source Type: research